MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1093/noajnl/vdag185

Медицинская библиотека · Neuro-oncology advances · 2026

A clinical decision-support framework to differentiate radiation necrosis from tumor progression in brain metastases.

Ocaña-Tienda Beatriz, Chen Zhou Zhao Hui, Ramos Ana, Ortiz de Mendivil Ana, Nagib-Raya Fatima, Asenjo Beatriz, Bastero Alberto, Tramblin Carlos, Arana Estanislao, Pérez-García Víctor M

СтатьяПеревод в очереди

Аннотация

BACKGROUND

Differentiating radiation necrosis (RN) from tumor progression (TP) after stereotactic radiotherapy (SRT) in brain metastases (BMs) is a clinically consequential problem, as conventional MRI frequently fails to distinguish between them. Misclassification can lead to inappropriate treatment decisions or delayed therapy. The objective of this study was to develop a clinically interpretable, data-driven model that integrates lesion growth dynamics with routinely available clinical variables to improve discrimination between RN and TP.

METHODS

We retrospectively analyzed 175 BMs from 6 institutions. Lesion volumes were extracted from three consecutive contrast-enhanced T1-weighted MRI, and growth dynamics were quantified by estimating the growth exponent β. Clinical and treatment-related variables were systematically evaluated, and a multivariable predictive model was trained on a development cohort (n = 131) and validated on an external cohort (n = 44).

RESULTS

The final model combined β, primary tumor histology, and SRT modality. In the development cohort, the model demonstrated strong discriminative performance (AUC = 0.887). External validation confirmed generalizability, achieving an overall accuracy of 0.75, with high specificity (0.85) and positive predictive value (0.92) for RN. Incorrect classifications were largely confined to an intermediate-probability zone, while predictions at low and high probability extremes were highly reliable. The model was translated into a freely accessible, web-based tool to facilitate clinical decision-making.

CONCLUSIONS

By integrating lesion growth dynamics with routine clinical variables, this probability-based framework supports clinically meaningful differentiation between RN and TP. Its ability to explicitly represent diagnostic uncertainty, together with external validation, highlights its potential utility as a decision-support tool in the management of BMs.

Для цитирования: Ocaña-Tienda Beatriz, Chen Zhou Zhao Hui, Ramos Ana, Ortiz de Mendivil Ana, Nagib-Raya Fatima, Asenjo Beatriz, Bastero Alberto, Tramblin Carlos, Arana Estanislao, Pérez-García Víctor M. A clinical decision-support framework to differentiate radiation necrosis from tumor progression in brain metastases.. Neuro-oncology advances. 2026. DOI: 10.1093/noajnl/vdag185.
Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.